Voriconazole for IPA in Chinese Patients With COPD

Clinical trial NCT02234739 · UNKNOWN

Trial details

NCT number: NCT02234739
Sponsor: Red Cross Hospital, Hangzhou, China
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Invasive Pulmonary Aspergillosis COPD

Start date: 2014-10-01
Primary completion: 2016-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.